Welcome to our dedicated page for National Health Investors news (Ticker: $NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect National Health Investors's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of National Health Investors's position in the market.
National Health Investors, Inc. (NHI) filed a supplemental proxy statement with the SEC detailing steps taken by the Board of Directors in response to stockholders' concerns. The Board plans to propose amending the Articles of Incorporation, search for a new director, and evaluate Board composition.
National Health Investors, Inc. (NYSE:NHI) will pay a second quarter dividend of $0.90 per common share on August 2, 2024, to stockholders of record as of June 28, 2024.
National Health Investors, Inc. (NYSE:NHI) has issued an investor update focusing on their real estate investments in senior housing and medical facilities. NHI's diverse portfolio includes various types of healthcare properties. For more details, visit their website.
National Health Investors, Inc. (NYSE:NHI) announced its Q1 2024 results, showing net income per share of $0.71, NAREIT FFO per share of $1.10, and Normalized FFO per share of $1.12. The company updated its 2024 annual guidance and reported various financial figures. NHI's CEO highlighted deferral repayments, revenue growth, and raised guidance for the full year, emphasizing internal growth potential and financial strength.